Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 121,860,176
  • Shares Outstanding, K 2,035,753
  • Annual Sales, $ 48,194 M
  • Annual Income, $ 7,054 M
  • EBIT $ 12,643 M
  • EBITDA $ 22,243 M
  • 60-Month Beta 0.29
  • Price/Sales 2.53
  • Price/Cash Flow 7.69
  • Price/Book 6.56

Options Overview Details

View History
  • Implied Volatility 26.40% (+0.28%)
  • Historical Volatility 27.73%
  • IV Percentile 17%
  • IV Rank 16.71%
  • IV High 55.70% on 04/10/25
  • IV Low 20.52% on 12/31/25
  • Expected Move (DTE 7) 1.40 (2.31%)
  • Put/Call Vol Ratio 0.26
  • Today's Volume 36,183
  • Volume Avg (30-Day) 28,884
  • Put/Call OI Ratio 0.72
  • Today's Open Interest 651,769
  • Open Int (30-Day) 607,179
  • Expected Range 59.34 to 62.14

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 29 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.48
  • Number of Estimates 9
  • High Estimate 1.61
  • Low Estimate 1.33
  • Prior Year 1.80
  • Growth Rate Est. (year over year) -17.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
53.54 +13.44%
on 01/21/26
62.05 -2.11%
on 02/06/26
+4.82 (+8.62%)
since 01/13/26
3-Month
45.26 +34.19%
on 11/20/25
62.05 -2.11%
on 02/06/26
+12.11 (+24.90%)
since 11/13/25
52-Week
42.52 +42.85%
on 10/29/25
63.33 -4.09%
on 03/11/25
+4.77 (+8.52%)
since 02/13/25

Most Recent Stories

More News
The 5 Most Interesting Analyst Questions From Bristol-Myers Squibb’s Q4 Earnings Call

The 5 Most Interesting Analyst Questions From Bristol-Myers Squibb’s Q4 Earnings Call

BMY : 60.74 (+1.47%)
These Low IV Stocks May Be Setting Up for an Explosive Move

Market volatility has dropped since the recent correction, but with plenty of items on the news front, we could see a volatility spike at any point. That could mean it’s a good time to look for stock...

AAPL : 255.78 (-2.27%)
IBKR : 74.75 (+2.31%)
TSLA : 417.44 (+0.09%)
BAC : 52.55 (+0.06%)
COP : 111.43 (+0.54%)
WFC : 86.98 (+0.80%)
KMI : 32.32 (+1.99%)
WBD : 27.99 (-0.43%)
SCHW : 93.72 (-1.10%)
BMY : 60.74 (+1.47%)
BMY Q4 Deep Dive: Growth Portfolio Offsets Legacy Pressure, Pipeline Readouts in Focus

BMY Q4 Deep Dive: Growth Portfolio Offsets Legacy Pressure, Pipeline Readouts in Focus

BMY : 60.74 (+1.47%)
Stocks Settle Lower as Tech and Crypto are Routed

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed down -1.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.38%. March...

MSTR : 133.88 (+8.85%)
GOOGL : 305.72 (-1.06%)
ARES : 133.88 (-0.04%)
AAPL : 255.78 (-2.27%)
GLXY : 21.66 (+7.49%)
DDOG : 125.20 (-0.74%)
ALGN : 186.77 (+1.58%)
$IUXX : 24,732.73 (+0.18%)
COIN : 164.32 (+16.46%)
ZNH26 : 113-055s (+0.33%)
MSFT : 401.32 (-0.13%)
TSLA : 417.44 (+0.09%)
Stocks Retreat as Tech Stocks Fall and the US Labor Market Weakens

The S&P 500 Index ($SPX ) (SPY ) today is down -1.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.49%. March E-mini S&P futures...

MSTR : 133.88 (+8.85%)
GOOGL : 305.72 (-1.06%)
ARES : 133.88 (-0.04%)
AAPL : 255.78 (-2.27%)
GLXY : 21.66 (+7.49%)
ALGN : 186.77 (+1.58%)
$IUXX : 24,732.73 (+0.18%)
COIN : 164.32 (+16.46%)
ZNH26 : 113-055s (+0.33%)
MSFT : 401.32 (-0.13%)
TSLA : 417.44 (+0.09%)
ESH26 : 6,850.50s (-0.01%)
Stocks Extend Slump as Tech Rout Deepens

The S&P 500 Index ($SPX ) (SPY ) today is down -0.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.40%. March E-mini S&P futures...

MSTR : 133.88 (+8.85%)
GOOGL : 305.72 (-1.06%)
ARES : 133.88 (-0.04%)
AAPL : 255.78 (-2.27%)
ADI : 337.10 (+1.73%)
GLXY : 21.66 (+7.49%)
TXN : 226.16 (+1.42%)
ALGN : 186.77 (+1.58%)
$IUXX : 24,732.73 (+0.18%)
COIN : 164.32 (+16.46%)
ZNH26 : 113-055s (+0.33%)
MSFT : 401.32 (-0.13%)
Bristol-Myers Squibb (NYSE:BMY) Reports Strong Q4 CY2025

Bristol-Myers Squibb (NYSE:BMY) Reports Strong Q4 CY2025

BMY : 60.74 (+1.47%)
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025

Bristol Myers Squibb (NYSE: BMY) today reported fourth quarter and full-year 2025 financial results. Visit the company’s Investor Relations website at http://investor.bms.com...

BMY : 60.74 (+1.47%)
Stocks Slip Before the Open as Tech-Led Selloff Continues, Amazon Earnings on Tap

March S&P 500 E-Mini futures (ESH26) are down -0.42%, and March Nasdaq 100 E-Mini futures (NQH26) are down -0.55% this morning, pointing to further losses on Wall Street as technology stocks face renewed...

GOOGL : 305.72 (-1.06%)
NVDA : 182.81 (-2.21%)
AVGO : 325.17 (-1.81%)
BNP.FP : 89.400 (-2.39%)
COP : 111.43 (+0.54%)
SHEL.LN : 2,869.115 (-0.65%)
BSX : 74.73 (+0.82%)
SMCI : 30.54 (+0.36%)
ALGN : 186.77 (+1.58%)
ESH26 : 6,850.50s (-0.01%)
BMY : 60.74 (+1.47%)
TSLA : 417.44 (+0.09%)
Bristol Myers Squibb Teams Up with Kasey Keller to Share His Lymphoma Journey with Breyanzi

Soccer Hall-of-Famer is speaking out for the first time about his private battle with lymphoma and treatment with Breyanzi in honor of World Cancer Day ...

BMY : 60.74 (+1.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers...

See More

Key Turning Points

3rd Resistance Point 62.04
2nd Resistance Point 61.49
1st Resistance Point 61.12
Last Price 60.74
1st Support Level 60.19
2nd Support Level 59.64
3rd Support Level 59.27

See More

52-Week High 63.33
Last Price 60.74
Fibonacci 61.8% 55.38
Fibonacci 50% 52.93
Fibonacci 38.2% 50.47
52-Week Low 42.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar